| 1 | SIEGEL R L, MILLER K D, FUCHS H E, et al.. Cancer statistics, 2022[J]. CA Cancer J. Clin., 2022, 72(1): 7-33. | 
																													
																							| 2 | DUFOUR J F, JOHNSON P. Liver cancer: from molecular pathogenesis to new therapies: summary of the EASL single topic conference[J]. J. Hepatol., 2010, 52(2): 296-304. | 
																													
																							| 3 | CHEN W, ZHENG R, BAADE P D, et al.. Cancer statistics in China, 2015[J]. CA Cancer J. Clin., 2016, 66(2): 115-132. | 
																													
																							| 4 | CUI Y, JIA J. Update on epidemiology of hepatitis B and C in China[J]. J. Gastroenterol. Hepatol., 2013, 1: 7-10. | 
																													
																							| 5 | PIÑERO F, DIRCHWOLF M, PESSÔA M G. Biomarkers in hepatocellular carcinoma: diagnosis, prognosis and treatment response assessment[J/OL]. Cells, 2020, 9(6): 1370[2020-06-01]. . | 
																													
																							| 6 | SIM H W, KNOX J. Hepatocellular carcinoma in the era of immunotherapy[J]. Curr. Probl. Cancer, 2018, 42(1): 40-48. | 
																													
																							| 7 | JIŘÍ T, IGOR K. Hepatocellular carcinoma future treatment options[J]. Klin. Onkol., 2020, 33: 26-29. | 
																													
																							| 8 | NJEI B, ROTMAN Y, DITAH I, et al.. Emerging trends in hepatocellular carcinoma incidence and mortality[J]. Hepatology, 2015, 61(1): 191-199. | 
																													
																							| 9 | SAMANT H, AMIRI H S, ZIBARI G B. Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management[J]. J. Gastrointest. Oncol., 2021, 12(2): 361-373. | 
																													
																							| 10 | YIM H J, SUH S J, UM S H. Current management of hepatocellular carcinoma: an Eastern perspective[J]. World J. Gastroenterol., 2015, 21(13): 3826-3842. | 
																													
																							| 11 | KIM M, COSTELLO J. DNA methylation: an epigenetic mark of cellular memory[J]. Exp. Mol. Med., 2017, 49(4): 1-8. | 
																													
																							| 12 | ORTEGA-RECALDE O, HORE T A. DNA methylation in the vertebrate germline: balancing memory and erasure[J]. Essays. Biochem., 2019, 63(6): 649-661. | 
																													
																							| 13 | ZHANG L, LU Q, CHANG C. Epigenetics in health and disease[J]. Adv. Exp. Med. Biol., 2020, 1253: 3-55. | 
																													
																							| 14 | HEYN H, ESTELLER M. DNA methylation profiling in the clinic: applications and challenges[J]. Nat. Rev. Genet., 2012, 13(10): 679-692. | 
																													
																							| 15 | VILLANUEVA A, PORTELA A, SAYOLS S, et al.. DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma[J]. Hepatology, 2015, 61(6): 1945-1956. | 
																													
																							| 16 | ALLY A, BALASUNDARAM M, CARLSEN R, et al.. Comprehensive and integrative genomic characterization of hepatocellular carcinoma[J]. Cell, 2017, 169(7): 1327-1341. | 
																													
																							| 17 | ZHOU J, GUO H, LIU L, et al.. Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma[J]. J. Cell. Mol. Med., 2021, 25(3): 1633-1644. | 
																													
																							| 18 | 张淑梅,张彬,刘军厚,等.癌症中DNA甲基化基因模块筛选[J].生物信息学,2014,(3):189-195. | 
																													
																							| 19 | ARAN D, SIROTA M, BUTTE A J. Systematic pan-cancer analysis of tumour purity[J/OL]. Nat. Commun., 2015, 6(1): 8971[2015-12-04]. . | 
																													
																							| 20 | CHAUDHARY K, POIRION O B, LU L, et al.. Deep learning-based multi-omics integration robustly predicts survival in liver cancer[J]. Clin. Cancer. Res., 2018, 24(6): 1248-1259. | 
																													
																							| 21 | 雍嘉欣,韦权峰,刘尚辉.基于TCGA和GEO数据库的胃癌lncRNA筛选与ceRNA网络构建[J].生物技术进展,2022, 12(1):149-157. |